Looking back at the previous drugs of the week, they were all rather small molecules with either interesting features and/or thrilling adverse effects.
This week, though, I have opted for a huge molecule, rifampin, with remarkable properties. Somehow, you should consider it a masterpiece.

Now, this ginormous drug is one of the derivatives of an antibiotic, rifamycin, produced by Streptomyces mediterranei. It has terrific effectiveness against cocci, some enteric bacteria and mycobacteria. In particular, rifampin is a typical antimycobacterial drug.
The reason why it can kill mycobacteria is due to its lovely pharmacodynamics: it stops bacterial RNA synthesis by binding to the beta subunit of bacterial RNA polymerase. Human polymerase has no affinity for this molecule, so the drug is selectively bactericidal.
Pharmacokinetic is fantastic too. Orally administered, rifampin is well absorbed, reaches almost every centimeter of your body, where those vicious mycobacteria may be. Only the cerebrospinal fluids are hard to be reached, unless there's some meningeal inflammation going on.
Well, theoretically, it seems all nice and smooth, but, unfortunately, you always have to bear in mind resistance:
rpoB is the gene which codes for the said beta subunit, and there is a wide spectrum of point mutations a bacterium can choose from to protect itself. And mycobacteria are a class of their own, when it comes to develop resistance. Not to mention their ability to become dormant in order to protect themselves.
Basically, we use rifampin when we get tuberculosis, often with another drug capable of killing mycobacterium tuberculosis because no cross-resistance has been noticed to date.
Mr. I-don't-like-to-grow-in-vitro M. leprea can be attacked using dapsone AND rifampin.
This drug is commonly used prophylactically in children who might develop Haemophilus influenzae type b disease.
However, my favourite regimen remains a triple therapy of rifampin, ceftriaxone and, ready for this, vancomycin to tackle meningitis caused by worryingly increasing penicillin-resistant pneumococci.
Sadly, there are many side effects.
Urine, sweat, tears and even contact lenses get orange (very popular in the Netherlands, I guess).
Light chain proteinuria is usually reported.
A flu-like syndrome can also occur: fever, myalgias, anemia, thrombocytopenia and tubular necrosis being the features of this phenomenon.
Although they are reported, jaundice and hepatitis are rare of consequences of the use of rifampin.
Interestingly, this drug is a potent inducer of citochrome P450 enzymes. This means that methadone, anticoagulants and contraceptives are inactivated, as well as drugs such as ketoconazole, chloramphenicol and theophylline.